Startseite
Impressum
Datenschutz
 
Volume 37, 12 May 2006 5/2006
 
  SPOT ON
 

Editorials, studies, guidelines: How much dependency on industry can be tolerated?

 
  NEW ON THE MARKET
 

Transdermal rotigotine (NEUPRO) for Parkinson's disease
Parkinson's disease: Initial therapy with levodopa or dopamine agonists?

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

MOSES-study with eprosartane (EMESTAR,. TEVETEN) - What is the value of angiotensin-II-receptor antagonists in hypertension

 
  IN BRIEF
 

Anti-arrhythmic drugs for atrial fibrillation
Influenza: Do neuraminidase inhibitors reduce mortality?
Homocysteine: - Vitamin cocktail with B6, B12, and folic acid again without benefit

 
  CURRENT ADR NETWORK REPORT

Diplopia with oseltamivir

 
  SIDE EFFECTS
 

Abuse potential of the antiepileptic pregabalin (LYRICA)

 
© arznei-telegramm5/2006